The company has already stockpiled over $500 million in pre-launch inventory, signaling confidence in its success
Common adjustments include increasing semaglutide dose every 4 weeks (starting low and titrating upward) or switching to a dual-compound option like GLP-Squared Injection if single-agent therapy plateaus
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 20062013
Supplementary Table 1), and in people of European ancestry 11 (BMI % = 12.1% in Europeans versus 10.6% in non-Europeans
No liver/kidney toxicity in studies
The FDA has formally recognized Model-Informed Drug Development (MIDD) under PDUFA VI as a tool for dose optimization, supportive efficacy evidence, and clinical trial design (Wang et al., 2019, DOI)